Web Analytics

3 Latest Announced Rounds

  • $4,100,000
    Seed

    3 Investors

    Software Development
    Sep 19th, 2025
  • $2,600,000
    Pre-Seed

    1 Investors

    Travel Arrangements
    Sep 19th, 2025
  • $34,000,000
    Series B
    Construction
    Sep 19th, 2025
$1,441.27M Raised in 60 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Artax Biopharma Inc

start up
United States - Cambridge, MA
  • 07/08/2024
  • Unknown
  • $8,000,000

Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases. Artax Biopharma is developing the next generation of drugs targeting the interaction between TCR and Nck, which is responsible for T cell activation. Specific control over T cells through TCR, provides the compounds with the potential to become first-in-class immunomodulators for the treatment of a wide range of autoimmune and inflammatory diseases.


Related People

Rob ArmstrongFounder

Rob Armstrong United States - Greater Boston

N/A